Musculoskeletal system

Filters
Category
Release Form
Primary Package
Status
Dossier Type
Search

Musculoskeletal system

Atracurium

Musculoskeletal system

Solution for Injection

Solution for Injection

10mg/mL: 2.5mL, 5mL

Ampoule, Rx, EU CTD
More Less

Chondroitin sulfate + Levomenthol

Musculoskeletal system

Ointment

Ointment

tube 30g

Tube, OTC, CTD
More Less

Glucosamine sulphate

Musculoskeletal system

Unit Dose Powder for oral Solution Sachet Solution for Injection

Unit Dose Powder for oral Solution Sachet

1.5g

Sachet, Rx, CTD
Solution for Injection

200mg/mL: 2mL + solvent in Ampoule 1mL

Ampoule, Rx, CTD
More Less

Ibuprofen

Musculoskeletal system

Tablets

Tablets

200mg, 400mg, 600mg

Blister, OTC/Rx, EU CTD
More Less

Ketoprofen

Musculoskeletal system

Gel

Gel

2.5% tube 30g

Tube, Rx, CTD
More Less

Ketorolac

Musculoskeletal system

Solution for Injection Film-coated Tablets

Solution for Injection

30mg/mL: 1mL

Ampoule, Rx, CTD
Film-coated Tablets

10mg

Blister, Rx, CTD
More Less

Meloxicam

Musculoskeletal system

Solution for Injection Tablets

Solution for Injection

1%: 1.5mL

Ampoule, Rx, EU CTD
Tablets

7.5mg, 15mg

Blister, Rx, EU CTD
More Less

Nimesulide

Musculoskeletal system

Unit Dose Powder for oral Suspension Sachet

Unit Dose Powder for oral Suspension Sachet

100mg

Sachet, Rx, CTD
More Less

Tolperisone

Musculoskeletal system

Film-coated Tablets Solution for Injection

Film-coated Tablets

50mg, 150mg

Blister, Rx, CTD
Solution for Injection

100mg/mL: 1mL

Ampoule, Rx, CTD
More Less

Musculoskeletal care is procurement-sensitive: pain control, anti-inflammatory protocols, and supportive therapies should stay consistent across orthopedics, rheumatology, rehab, and long-term care. In Europe, hospitals usually verify that a bone health treatment distributor can document quality, dossier readiness, and supply continuity before a contract goes live.

Musculoskeletal System Product Portfolio

The musculoskeletal section on https://farmak.com/products/ centers on anti-inflammatory therapy, joint-support products, topical symptom relief, and supervised muscle relaxation.

Our NSAID line is designed for acute pain pathways and routine inflammatory care and offers both oral and parenteral options, such as:

  • Ibuprofen tablets;
  • Meloxicam tablets;
  • Ketorolac solution for injection;
  • Nimesulide unit dose powder for oral suspension.

For most institutions, this NSAID layer is the baseline expected from a joint pain management drugs supplier.

DMARD sourcing depends on local registration, so the final DMARD scope is confirmed during tender planning against country rules and clinical governance. We can scope systemic corticosteroids where locally registered when pain pathways require more than NSAIDs, including dexamethasone injection, hydrocortisone acetate injectable suspension, and methylprednisolone tablets.

Hospital & Clinical Applications

As a muscle relaxant supplier, Farmak International supplies musculoskeletal therapies for four settings across Europe:

  • Orthopedic and rheumatology departments in hospitals that need a musculoskeletal system medications supplier who keeps standard pain and inflammation protocols stable across wards.
  • Pain management and rehabilitation clinics that combine scheduled visits, predictable refills, and clear counseling. We align supply to this rhythm with formats that work for outpatient dispensing and step-down care, including supervised muscle relaxation programs.
  • Pharmacy procurement for arthritis and musculoskeletal disorder treatments. As an arthritis treatment drugs supplier, here we keep product parameters clear at the item level and provide the documentation packages procurement committees need when comparing alternatives across arthritis and broader musculoskeletal treatment lines.
  • Long-term care facilities for chronic musculoskeletal disease management. We support them with predictable ordering cycles and practical pack planning, including supportive lines often procured as part of chronic care. Such a model is especially relevant when a musculoskeletal disease drugs distributor supports both hospitals and affiliated long-term care sites.

Farmak International’s experience helps hospitals maintain treatment continuity across orthopedic, rheumatology, rehabilitation, and long-term care settings.

Product Specifications & Formulations

Each item in our catalog is presented with release form, strength, primary package, status, and dossier type, which helps musculoskeletal procurement teamssupport consistent ordering without specification ambiguity.

Oral anti-inflammatory therapies are supplied in unit-controlled packs for routine dispensing. When parenteral treatment is needed, we provide ampoule-based injectables such as meloxicam, ketorolac, and tolperisone, and we also list glucosamine sulphate supplied with solvent in ampoules. For step-down care and outpatient symptom relief, the catalog includes topical packs in tubes, including ketoprofen gel and chondroitin sulfate + levomenthol ointment.

Packaging is selected to match real use: blisters and sachets for oral dosing, ampoules for injections, and tubes for localized therapy. We adapt pack sizes and labeling to market requirements, including multilingual patient information. Storage follows the locally approved label, supported by GDP handling and temperature-controlled logistics when needed.

Quality Standards & Regulatory Compliance

Farmak International upholds stringent quality standards as a manufacturer of musculoskeletal pain medication serving European healthcare institutions.

Facilities supporting the anti-inflammatory musculoskeletal drugs supplier portfolio operate in compliance with EU-GMP requirements, with validated production and quality control processes appropriate to each dosage form.. Production follows validated processes, designed to control and minimize cross-contamination risks between dosage forms.. External audits verify compliance for muscle relaxants pharmaceutical supplier B2B products used in high-volume hospital settings.

Pharmacovigilance activities support ongoing safety monitoring in accordance with regulatory reporting obligations for NSAIDs and other musculoskeletal therapies. Farmak International maintains defined pharmacovigilance contact points in accordance with regulatory requirements. The same renewal cycle is applied to suppliers acting as a rheumatoid arthritis medications distributor in hospital formularies.

Our supply chain operations include GDP-aligned warehousing and execution that cover country-specific labeling, multilingual patient information, and temperature control when required by the local label and route planning.

Ordering, Supply & Partnership Benefits

Institutional supply at Farmak International, a trusted supplier of muscle relaxants, is built on predictable availability, clear documentation, and logistics that protect product integrity across handoffs in Europe. We execute deliveries through air, sea, and land routes and work with forwarding partners that support customs clearance and controlled handling. When a product or route requires temperature control, we maintain cold-chain requirements and keep distribution aligned with Good Distribution Practice (GDP) expectations.

To confirm lead times, tender documentation, and the best pack formats for your facilities, contact Farmak International and share your target country and product shortlist from our catalog.